AP Biosciences (ROCO:6945) Days Payable : 0.00 (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is AP Biosciences Days Payable?

AP Biosciences's average Accounts Payable for the six months ended in Jun. 2024 was NT$0.00 Mil. AP Biosciences's Cost of Goods Sold for the six months ended in Jun. 2024 was NT$0.00 Mil.

The historical rank and industry rank for AP Biosciences's Days Payable or its related term are showing as below:

ROCO:6945's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 127.37
* Ranked among companies with meaningful Days Payable only.

AP Biosciences's Days Payable stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00).

AP Biosciences Days Payable Historical Data

The historical data trend for AP Biosciences's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AP Biosciences Days Payable Chart

AP Biosciences Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Days Payable

AP Biosciences Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Payable	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of AP Biosciences's Days Payable

For the Biotechnology subindustry, AP Biosciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AP Biosciences's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AP Biosciences's Days Payable distribution charts can be found below:

* The bar in red indicates where AP Biosciences's Days Payable falls into.

AP Biosciences Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

AP Biosciences's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

AP Biosciences's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 2
=	0					/	0	*	365 / 2
=	N/A

AP Biosciences Days Payable Related Terms

Thank you for viewing the detailed overview of AP Biosciences's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

AP Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3, Park Street, 17th Floor, Taipei, TWN

Website

https://www.apbioinc.com

AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.

AP Biosciences Headlines

No Headlines